Piscopo, L.; Zampella, E.; Volpe, F.; Gaudieri, V.; Nappi, C.; Cutillo, P.; Volpicelli, F.; Falzarano, M.; Pace, L.; Cuocolo, A.;
et al. Efficacy of Empirical Radioiodine Therapy in Patients with Differentiated Thyroid Cancer and Elevated Serum Thyroglobulin without Evidence of Structural Disease: A Propensity Score Analysis. Cancers 2023, 15, 4196.
https://doi.org/10.3390/cancers15164196
AMA Style
Piscopo L, Zampella E, Volpe F, Gaudieri V, Nappi C, Cutillo P, Volpicelli F, Falzarano M, Pace L, Cuocolo A,
et al. Efficacy of Empirical Radioiodine Therapy in Patients with Differentiated Thyroid Cancer and Elevated Serum Thyroglobulin without Evidence of Structural Disease: A Propensity Score Analysis. Cancers. 2023; 15(16):4196.
https://doi.org/10.3390/cancers15164196
Chicago/Turabian Style
Piscopo, Leandra, Emilia Zampella, Fabio Volpe, Valeria Gaudieri, Carmela Nappi, Paolo Cutillo, Federica Volpicelli, Maria Falzarano, Leonardo Pace, Alberto Cuocolo,
and et al. 2023. "Efficacy of Empirical Radioiodine Therapy in Patients with Differentiated Thyroid Cancer and Elevated Serum Thyroglobulin without Evidence of Structural Disease: A Propensity Score Analysis" Cancers 15, no. 16: 4196.
https://doi.org/10.3390/cancers15164196
APA Style
Piscopo, L., Zampella, E., Volpe, F., Gaudieri, V., Nappi, C., Cutillo, P., Volpicelli, F., Falzarano, M., Pace, L., Cuocolo, A., & Klain, M.
(2023). Efficacy of Empirical Radioiodine Therapy in Patients with Differentiated Thyroid Cancer and Elevated Serum Thyroglobulin without Evidence of Structural Disease: A Propensity Score Analysis. Cancers, 15(16), 4196.
https://doi.org/10.3390/cancers15164196
